ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 262 filers reported holding ICU MED INC in Q4 2017. The put-call ratio across all filers is 1.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $86,594,533 | -32.9% | 727,624 | +0.5% | 0.01% | -28.6% |
Q2 2023 | $129,011,876 | +0.3% | 724,013 | -7.1% | 0.01% | -12.5% |
Q1 2023 | $128,620,000 | +108160.5% | 779,705 | +3.4% | 0.02% | 0.0% |
Q4 2022 | $118,806 | -99.9% | 754,421 | +1.1% | 0.02% | 0.0% |
Q3 2022 | $112,373,000 | -9.9% | 746,165 | -1.7% | 0.02% | -5.9% |
Q2 2022 | $124,722,000 | -30.1% | 758,702 | -5.4% | 0.02% | -19.0% |
Q1 2022 | $178,503,000 | -13.8% | 801,759 | -8.1% | 0.02% | -12.5% |
Q4 2021 | $207,040,000 | +2.4% | 872,331 | +0.6% | 0.02% | -4.0% |
Q3 2021 | $202,270,000 | +9.8% | 866,701 | -3.2% | 0.02% | +13.6% |
Q2 2021 | $184,247,000 | -1.4% | 895,270 | -1.5% | 0.02% | -12.0% |
Q1 2021 | $186,774,000 | +12.8% | 909,138 | +17.8% | 0.02% | +4.2% |
Q4 2020 | $165,532,000 | +32.5% | 771,746 | +13.2% | 0.02% | +14.3% |
Q3 2020 | $124,919,000 | +4.6% | 681,909 | +5.3% | 0.02% | -8.7% |
Q2 2020 | $119,374,000 | -3.6% | 647,683 | +5.5% | 0.02% | -20.7% |
Q1 2020 | $123,846,000 | +8.0% | 613,802 | +0.2% | 0.03% | +38.1% |
Q4 2019 | $114,679,000 | +21.0% | 612,864 | +3.2% | 0.02% | +10.5% |
Q3 2019 | $94,756,000 | -29.2% | 593,711 | +10.0% | 0.02% | -26.9% |
Q2 2019 | $133,867,000 | +8.0% | 539,633 | +4.2% | 0.03% | +4.0% |
Q1 2019 | $123,902,000 | +6.1% | 517,703 | +1.8% | 0.02% | -7.4% |
Q4 2018 | $116,809,000 | -15.8% | 508,682 | +3.6% | 0.03% | 0.0% |
Q3 2018 | $138,799,000 | -7.8% | 490,888 | -4.3% | 0.03% | -12.9% |
Q2 2018 | $150,615,000 | +26.2% | 512,901 | +8.4% | 0.03% | +19.2% |
Q1 2018 | $119,382,000 | +24.8% | 472,988 | +6.8% | 0.03% | +30.0% |
Q4 2017 | $95,691,000 | +19.4% | 443,011 | +2.5% | 0.02% | +11.1% |
Q3 2017 | $80,122,000 | +11.2% | 432,281 | +3.5% | 0.02% | +12.5% |
Q2 2017 | $72,061,000 | +14.4% | 417,744 | +1.3% | 0.02% | +14.3% |
Q1 2017 | $62,973,000 | -2.7% | 412,388 | -6.1% | 0.01% | -12.5% |
Q4 2016 | $64,733,000 | +34.8% | 439,309 | +15.6% | 0.02% | +33.3% |
Q3 2016 | $48,032,000 | +37.4% | 380,059 | +22.6% | 0.01% | +33.3% |
Q2 2016 | $34,953,000 | +81.4% | 309,998 | +67.5% | 0.01% | +80.0% |
Q1 2016 | $19,267,000 | +50.9% | 185,078 | +63.5% | 0.01% | +66.7% |
Q4 2015 | $12,765,000 | -1.0% | 113,187 | -3.8% | 0.00% | 0.0% |
Q3 2015 | $12,889,000 | -1.8% | 117,712 | -14.2% | 0.00% | 0.0% |
Q2 2015 | $13,124,000 | +14.4% | 137,199 | +11.4% | 0.00% | 0.0% |
Q1 2015 | $11,474,000 | +420.1% | 123,191 | +357.3% | 0.00% | +200.0% |
Q4 2014 | $2,206,000 | +205.1% | 26,938 | +139.4% | 0.00% | – |
Q3 2014 | $723,000 | +1.3% | 11,250 | -4.1% | 0.00% | – |
Q2 2014 | $714,000 | +29.3% | 11,733 | +27.1% | 0.00% | – |
Q1 2014 | $552,000 | -66.7% | 9,233 | -64.5% | 0.00% | – |
Q4 2013 | $1,659,000 | -9.0% | 26,042 | -3.0% | 0.00% | -100.0% |
Q3 2013 | $1,823,000 | -21.8% | 26,839 | -17.0% | 0.00% | 0.0% |
Q2 2013 | $2,330,000 | – | 32,327 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EVR Research LP | 22,000 | $4,719,000 | 3.86% |
NUANCE INVESTMENTS, LLC | 901,483 | $193,359,000 | 3.73% |
Nitorum Capital, L.P. | 417,241 | $89,494,000 | 3.46% |
Tamarack Advisers, LP | 73,000 | $15,452,000 | 3.22% |
PFM Health Sciences, LP | 267,817 | $57,444,000 | 2.02% |
KIRR MARBACH & CO LLC /IN/ | 22,222 | $4,766,000 | 1.49% |
PURA VIDA INVESTMENTS, LLC | 174,399 | $37,407,000 | 1.36% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,584 | $554,000 | 0.88% |
Findlay Park Partners LLP | 528,825 | $113,428,000 | 0.79% |
Altium Capital Management LP | 9,321 | $1,999,000 | 0.75% |